Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | Director · President and CEO | May 15, 2026 | May 19, 2026 |
| Vera Therapeutics, Inc.VERA · Entity 4358 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,362,008 |
Last balance in matching sequence
After 2026-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-05-15 · Tax withholding · Disposed 128,497 · Balance 1,486,055 F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Row 2 · 2026-05-18 · Gift · Disposed 124,047 · Balance 1,362,008 F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,004,327 |
Reported balance
After 2026-05-18 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-05-18 · Gift · Acquired 124,047 · Balance 2,004,327 F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F4: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 17,728 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 17,728 F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025.
F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F4: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
Vera Therapeutics, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.35 · Expires 2036-05-20 | Direct | 17,084 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 17,084 · Balance 17,084 F1: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2023 Filed Nov 21, 2023 00:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 19,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000118 · wk-form4_1700525256.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,436,914 F1 · kind: On November 16, 2023, the Reporting Person gifted 19,020 shares of Exelixis, Inc. common stock ("Common Stock") to a donor advised fund. F2 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 21:54 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 116,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000116 · wk-form4_1699566849.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,455,934 F1 · kind: On November 7, 2023, the Reporting Person gifted 116,893 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 21:54 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 116,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000116 · wk-form4_1699566849.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 F1 · kind: On November 7, 2023, the Reporting Person gifted 116,893 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 610,000 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 06, 2023 Filed Sep 9, 2023 01:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 46,608 | $22.27 | $1,037,960.16 |
DisclosureSEC source: 0000939767-23-000107 · wk-form4_1694222864.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726,893 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 6, 2023. F3 · balance_after: Includes 610,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 06, 2023 Filed Sep 9, 2023 01:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 188,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000107 · wk-form4_1694222864.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773,501 F1 · date: On September 11, 2020, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 188,005 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F2 · shares: On September 6, 2023, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 150% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). The Reporting Person had already vested 1/3 of the Achieved Shares as a result of the Committee's certification that certain performance criteria had been achieved on August 3, 2022 and continuous service through August 15, 2023. Accordingly, the Committee's certification on September 6, 2023 resulted in the immediate vesting of 1/3 of the Achieved Shares, and 1/3 of the Achieved Shares will vest on November 15, 2024, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending on the level and timing of achievement of the performance criteria through December 31, 2024. F3 · balance_after: Includes 610,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 00:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 57,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000102 · wk-form4_1693961929.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,339,041 F4 · kind: Represents shares of Common Stock that the Reporting Person donated as a gift to a donor advised fund. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| August 31, 2023 Filed Sep 6, 2023 00:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 56,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000102 · wk-form4_1693961929.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,396,541 F1 · kind: On August 31, 2023, the Reporting Person gifted 56,221 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| August 31, 2023 Filed Sep 6, 2023 00:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 56,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000102 · wk-form4_1693961929.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,496 F1 · kind: On August 31, 2023, the Reporting Person gifted 56,221 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 515,997 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 28, 2023 Filed Aug 31, 2023 01:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 360,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0000939767-23-000100 · wk-form4_1693446470.xml · derivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 360,000 shares Expires 2023-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 360,000 shares of Common Stock, became fully exercisable on September 26, 2020. Read SEC document |
| August 28, 2023 Filed Aug 31, 2023 01:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 303,779 | $22.18 | $6,737,818.22 |
DisclosureSEC source: 0000939767-23-000100 · wk-form4_1693446470.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 641,717 F2 · shares: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 56,221 shares of Common Stock on the net exercise of a stock option to purchase 360,000 shares of Common Stock. The Issuer withheld 303,779 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on August 28, 2023 of $22.18. F1 · balance_after: Includes 515,997 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 28, 2023 Filed Aug 31, 2023 01:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 360,000 | $15.31 | $5,511,600.00 |
DisclosureSEC source: 0000939767-23-000100 · wk-form4_1693446470.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 515,997 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 23,304 | $21.51 | $501,269.04 |
DisclosureSEC source: 0000939767-23-000090 · wk-form4_1692318044.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,496 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on October 22, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on August 3, 2022. F2 · balance_after: Includes 515,997 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:14 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 33,518 | $19.18 | $642,875.24 |
DisclosureSEC source: 0000939767-23-000051 · wf-form4_168436885984151.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,800 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded March 4, 2022. F2 · balance_after: Includes 562,998 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:17 UTC | Vera Therapeutics, Inc. VERA · Entity 4358 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-23-029034 · doc4.xml · derivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2033-05-09 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 00:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 313,185 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000040 · wf-form4_168074090649421.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 642,318 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2024 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F3 · balance_after: Includes 630,601 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:46 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 11,522 | $18.08 | $208,317.76 |
DisclosureSEC source: 0000939767-23-000027 · wf-form4_167668835038706.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,133 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on December 15, 2021. F2 · balance_after: Includes 317,416 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 37,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000006 · wf-form4_167530160621659.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,340,320 F1 · kind: On January 30, 2023, the Reporting Person gifted 37,994 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 37,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000006 · wf-form4_167530160621659.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,655 F1 · kind: On January 30, 2023, the Reporting Person gifted 37,994 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 340,655 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 01:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0000939767-23-000005 · wf-form4_167478476355424.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2023-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 150,000 shares of Common Stock, became fully exercisable on February 11, 2020. Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 01:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 62,006 | $17.36 | $1,076,424.16 |
DisclosureSEC source: 0000939767-23-000005 · wf-form4_167478476355424.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,649 F4 · shares: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 37,994 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 62,006 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on January 24, 2023 of $17.36. Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 01:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $4.20 | $420,000.00 |
DisclosureSEC source: 0000939767-23-000005 · wf-form4_167478476355424.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2022 Filed Jan 27, 2023 01:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 106,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000005 · wf-form4_167478476355424.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,302,326 F1 · kind: On December 7, 2022, the Reporting Person gifted 106,010 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| December 07, 2022 Filed Jan 27, 2023 01:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 106,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000005 · wf-form4_167478476355424.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,655 F1 · kind: On December 7, 2022, the Reporting Person gifted 106,010 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 340,655 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 01:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 23,304 | $16.71 | $389,409.84 |
DisclosureSEC source: 0000939767-22-000112 · wf-form4_166873559968985.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,665 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on October 22, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on September 30, 2021. F2 · balance_after: Includes 340,655 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 03, 2022 Filed Aug 6, 2022 01:50 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 23,304 | $21.49 | $500,802.96 |
DisclosureSEC source: 0000939767-22-000089 · wf-form4_165975061464082.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,969 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on August 3, 2022. Read SEC document |
| August 03, 2022 Filed Aug 6, 2022 01:50 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 94,002 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000089 · wf-form4_165975061464082.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,273 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On October 22, 2020, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 188,005 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement of certain performance criteria as certified by the Compensation Committee (the "Committee"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F3 · shares: On August 3, 2022, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on August 15, 2023, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024. F4 · balance_after: Includes 387,656 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:18 UTC | Vera Therapeutics, Inc. VERA · Entity 4358 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0001209191-22-031857 · doc4.xml · derivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2032-05-23 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 02:04 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 270,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000039 · wf-form4_164679142275391.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,271 F3 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F4 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2023 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F5 · balance_after: Includes 340,655 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 02, 2022 Filed Mar 9, 2022 02:04 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000039 · wf-form4_164679142275391.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,196,316 F1 · kind: Represents shares of Exelixis, Inc. common stock that the Reporting Person donated as a gift to a donor advised fund. F2 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 01:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 59,044 | $18.59 | $1,097,627.96 |
DisclosureSEC source: 0000939767-22-000019 · wf-form4_164514636044976.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,856 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 01:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,103 | $18.59 | $113,454.77 |
DisclosureSEC source: 0000939767-22-000019 · wf-form4_164514636044976.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,900 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021. F2 · balance_after: Includes 70,240 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 23, 2021 Filed Feb 15, 2022 02:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 11,003 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000012 · wf-form5_164489043888525.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,246,316 F1 · kind: On December 23, 2021, the Reporting Person gifted 11,003 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| December 23, 2021 Filed Feb 15, 2022 02:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 11,003 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000012 · wf-form5_164489043888525.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,003 F1 · kind: On December 23, 2021, the Reporting Person gifted 11,003 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 194,003 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 01:41 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 12,236 | $17.00 | $208,012.00 |
DisclosureSEC source: 0000939767-21-000117 · wf-form4_163979168754039.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,006 F8 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 15, 2021. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 01:41 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 46,478 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000117 · wf-form4_163979168754039.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,242 F4 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F5 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 46,478 shares of common stock. The PSU award generally vests as follows: (i) 50% of the original number of shares subject to the award vest upon certification by the Compensation Committee (the "Committee") that Exelixis, Inc. has achieved certain performance criteria related to the submission of Investigational New Drug applications with the U.S. Food and Drug Administration, or equivalent applications or filings with a foreign governmental authority, with respect to product candidates discovered, in-licensed or acquired by Exelixis, Inc. (the "2018 PSU Goal"); and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F6 · shares: On December 15, 2021, the Committee convened to determine that the 2018 PSU Goal had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2023, subject to the Reporting Person's continuous service through that date. F7 · balance_after: Includes 194,003 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 29, 2021 Filed Dec 18, 2021 01:41 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 196,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000117 · wf-form4_163979168754039.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,235,313 F1 · kind: On November 29, 2021, the Reporting Person gifted 196,524 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 29, 2021 Filed Dec 18, 2021 01:41 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 196,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000117 · wf-form4_163979168754039.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,764 F1 · kind: On November 29, 2021, the Reporting Person gifted 196,524 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 170,764 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 177,132 | $18.10 | $3,206,089.20 |
DisclosureSEC source: 0000939767-21-000101 · wf-form4_163719916632747.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,288 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on October 22, 2020. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,118 | $18.10 | $110,735.80 |
DisclosureSEC source: 0000939767-21-000101 · wf-form4_163719916632747.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,420 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 2, 2020. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 10,530 | $18.10 | $190,593.00 |
DisclosureSEC source: 0000939767-21-000101 · wf-form4_163719916632747.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,538 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017. F2 · balance_after: Includes 170,764 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| October 22, 2021 Filed Oct 23, 2021 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 24,747 | $21.33 | $527,853.51 |
DisclosureSEC source: 0000939767-21-000091 · wf-form4_163494838598490.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,068 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on October 22, 2021. Read SEC document |
| October 22, 2021 Filed Oct 23, 2021 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 94,002 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000091 · wf-form4_163494838598490.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,815 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On October 22, 2020, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 188,005 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement of certain performance criteria as certified by the Compensation Committee (the "Committee"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F3 · shares: The Committee determined that certain performance criteria had been achieved, effective October 22, 2021, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on November 15, 2022, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024. F4 · balance_after: Includes 538,814 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 14, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 19,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,038,789 F5 · kind: On May 14, 2021, the Reporting Person gifted 19,722 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| May 14, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 19,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,813 F5 · kind: On May 14, 2021, the Reporting Person gifted 19,722 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| May 12, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · derivative · entry 7 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2023-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 150,000 shares of Common Stock, became fully exercisable on February 11, 2020. Read SEC document |
| May 12, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 30,278 | $25.16 | $761,794.48 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,535 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 19,722 shares of Common Stock on the net exercise of a stock option to purchase 50,000 shares of Common Stock. The Issuer withheld 30,278 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 12, 2021 of $25.16. Read SEC document |
| May 12, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 50,000 | $4.20 | $210,000.00 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 491,813 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 10, 2021 Filed May 15, 2021 00:51 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 40,616 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000051 · wf-form4_162103985398361.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,019,067 F1 · kind: Represents shares of Exelixis, Inc. common stock ("Common Stock") that the Reporting Person donated as a gift to a donor advised fund. F2 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| March 04, 2021 Filed Mar 6, 2021 01:04 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 494,700 | $0.00 Strike: $21.31 | $0.00 |
DisclosureSEC source: 0000939767-21-000036 · wf-form4_161499266657333.xml · derivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,700 Underlying: Common Stock · 494,700 shares Expires 2028-03-03 F5 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date. Read SEC document |
| February 24, 2021 Filed Mar 6, 2021 01:04 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 67,374 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000036 · wf-form4_161499266657333.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,059,683 F1 · kind: On February 24, 2021, the Reporting Person gifted 67,374 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.